PEER PERSPECTIVES: The Evolving Treatment Landscape in Melanoma

Over the past decade, countless therapies have been developed and approved by the Food and Drug Administration (FDA) for the treatment of melanoma.  What’s interesting to note about melanoma, is how the incidence of the disease is rising. In fact, data from the CDC shows that melanoma cases have doubled between 1982 and 2011. Unfortunately, many of these patients are often young and otherwise considered healthy. Patients are living longer after a melanoma diagnosis and some are even getting cured or achieving long-term remissions, even with metastatic disease.  Join us to stay up-to-date.